Terms: = Colorectal cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
43 results:
1. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract] [Full Text] [Related]
2. Global application of National Comprehensive cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement.
Wilson BE; Booth CM; Sullivan R; Aggarwal A; Sengar M; Jacob S; Bray F; Barton MB; Pearson SA
Lancet Oncol; 2023 Jun; 24(6):682-690. PubMed ID: 37269845
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the WNT/TCF pathway and the value of DCE-MRI in predicting and evaluating the efficacy of neoadjuvant radiotherapy and chemotherapy for locally advanced rectal cancer.
Cheng Q; Rong F; Ye S; Zheng B; Chen X; Ye N; Ling Q; Wu W
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):95-100. PubMed ID: 37224039
[TBL] [Abstract] [Full Text] [Related]
4. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Temmink SJD; Peeters KCMJ; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Melenhorst J; Burger JWA; Wolthuis A; Renehan AG; Figueiredo NL; Pares O; Martling A; Perez RO; Beets GL; van de Velde CJH; Nilsson PJ;
Br J Surg; 2023 May; 110(6):676-684. PubMed ID: 36972213
[TBL] [Abstract] [Full Text] [Related]
5. Sex-Specific Differences in the Risk of Heart Failure following Anti-HER2 Monoclonal Antibody Therapy.
Suzuki Y; Kaneko H; Tamura Y; Okada A; Michihata N; Jo T; Takeda N; Morita H; Fujiu K; Node K; Yasunaga H; Komuro I
Oncology; 2023; 101(6):358-361. PubMed ID: 36940681
[TBL] [Abstract] [Full Text] [Related]
6. Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal Tumors: 25-Year Experience in a Single Institution.
Park SJ; Park JS; Lee CS; Kang BJ; Jung CW
Clin Orthop Surg; 2023 Feb; 15(1):109-117. PubMed ID: 36778984
[TBL] [Abstract] [Full Text] [Related]
7. Construction of a colorectal cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract] [Full Text] [Related]
8. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor-node-metastasis classification of colorectal cancer and the 9th edition of the Japanese classification.
Shida D; Boku N; Nakamura Y; Yoshida T; Tanabe T; Yasui K; Takashima A; Kanemitsu Y
Cancer Med; 2021 Oct; 10(20):6937-6946. PubMed ID: 34587374
[TBL] [Abstract] [Full Text] [Related]
10. A Comprehensive Comparison of Early-Onset and Average-Onset colorectal cancers.
Cercek A; Chatila WK; Yaeger R; Walch H; Fernandes GDS; Krishnan A; Palmaira L; Maio A; Kemel Y; Srinivasan P; Bandlamudi C; Salo-Mullen E; Tejada PR; Belanfanti K; Galle J; Joseph V; Segal N; Varghese A; Reidy-Lagunes D; Shia J; Vakiani E; Mondaca S; Mendelsohn R; Lumish MA; Steinruecke F; Kemeny N; Connell L; Ganesh K; Markowitz A; Nash G; Guillem J; Smith JJ; Paty PB; Zhang L; Mandelker D; Birsoy O; Robson M; Offit K; Taylor B; Berger M; Solit D; Weiser M; Saltz LB; Aguilar JG; Schultz N; Diaz LA; Stadler ZK
J Natl Cancer Inst; 2021 Nov; 113(12):1683-1692. PubMed ID: 34405229
[TBL] [Abstract] [Full Text] [Related]
11. [Expression and clinicopathological significance of
Yang XG; Yang JW; Zhao PJ; Cheng W; Shi HB; Zhang B; Fu QC; Li Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):148-153. PubMed ID: 34008361
[TBL] [Abstract] [Full Text] [Related]
12. RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR-Containing Therapy Regimens in Metastatic colorectal cancer.
Schrock AB; Lee JK; Sandhu J; Madison R; Cho-Phan C; Snider JW; Castellanos E; Venstrom JM; Fakih M
Oncologist; 2021 Jun; 26(6):469-475. PubMed ID: 33465286
[TBL] [Abstract] [Full Text] [Related]
13. cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract] [Full Text] [Related]
14. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
Li J; Wang Y; Wang X; Yang Q
World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
[TBL] [Abstract] [Full Text] [Related]
15. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
[TBL] [Abstract] [Full Text] [Related]
16. The impact of primary tumor localization on survival and treatment outcomes in patients with metastatic colorectal cancer-a multicenter study.
Sahin S; Karatas F
J BUON; 2019; 24(2):479-487. PubMed ID: 31127994
[TBL] [Abstract] [Full Text] [Related]
17. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract] [Full Text] [Related]
18. Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic colorectal cancer in the United States.
Cho SK; Hay JW; Barzi A
Clin Colorectal Cancer; 2018 Dec; 17(4):e751-e761. PubMed ID: 30228027
[TBL] [Abstract] [Full Text] [Related]
19. A Comparative Analysis of Survival and Funding Discrepancies in cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract] [Full Text] [Related]
20. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
Yang J; Guo X; Wang M; Ma X; Ye X; Lin P
Sci Rep; 2017 Dec; 7(1):17166. PubMed ID: 29215037
[TBL] [Abstract] [Full Text] [Related]
[Next]
